Home > Uncategorized > What’s the core value of a genomics based diagnostic company?

What’s the core value of a genomics based diagnostic company?

A blog with no update is dead. I figured that I need to make it a habit to post thoughts in order to keep it alive. So, for today, before I get more time to elaborate more of my previous points about how to apply genomics and sequencing to the clinical world, let me post a question that I have been debating with myself these days.

To a biotech company, which mode works better:

  1. The company is based on a core technology. Markets are addressed by developing applications from the core technology;
  2. The company lives by its commercial set up, network and sales channels in a specific market. Applications are developed eitherbased on the company’s own technology or, more likely, by leveraging existing technologies that some other companies have developed.

One can, of course, find examples of companies living with either mode, or even a combination. There are pros and cons to both modes, apparently. Now, the real question is, for genomics based and clinically focused molecular diagnostic applications, what is the best choice? Strategy precedes tactics, and one should have a clear vision going into the business.

Categories: Uncategorized
  1. No comments yet.
  1. No trackbacks yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: